These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32169391)

  • 1. Comparative economic analysis of strategies for Japanese encephalitis vaccination of U.S. travelers.
    Carias C; Hills SL; Kahn EB; Adhikari BB; Fischer M; Meltzer MI
    Vaccine; 2020 Apr; 38(17):3351-3357. PubMed ID: 32169391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
    Hills SL; Walter EB; Atmar RL; Fischer M;
    MMWR Recomm Rep; 2019 Jul; 68(2):1-33. PubMed ID: 31518342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Full Economic Cost for Japanese Encephalitis Under Different Risk Scenarios for Business Travelers to Asia.
    Rogers WH; Bunn WB; Lerner D
    J Occup Environ Med; 2019 Jan; 61(1):16-20. PubMed ID: 30320627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of US travelers to Asia to assess compliance with recommendations for the use of Japanese encephalitis vaccine.
    Duffy MR; Reed C; Edelson PJ; Blumensaadt S; Crocker K; Griggs A; Biggerstaff BJ; Delorey MJ; Hayes EB; Fischer M
    J Travel Med; 2013; 20(3):165-70. PubMed ID: 23577862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland.
    Hatz C; Werlein J; Mutsch M; Hufnagel M; Behrens RH
    J Travel Med; 2009; 16(3):200-3. PubMed ID: 19538582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
    Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
    J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries.
    Hills SL; Fischer M; Biggerstaff BJ
    Vaccine; 2020 Feb; 38(9):2117-2121. PubMed ID: 31992482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis in a U.S. traveler returning from Thailand, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(5):123-5. PubMed ID: 15703694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Travelers to Asia Requiring Multidose Vaccine Schedules: Japanese Encephalitis and Rabies Prevention.
    Walker XJ; Barnett ED; Wilson ME; Macleod WB; Jentes ES; Karchmer AW; Hamer DH; Chen LH;
    J Travel Med; 2015; 22(6):403-9. PubMed ID: 26420372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case series of three US adults with Japanese encephalitis, 2010-2012.
    Hills SL; Stoltey J; Martínez D; Kim PY; Sheriff H; Zangeneh A; Eilerman SR; Fischer M
    J Travel Med; 2014; 21(5):310-3. PubMed ID: 24861145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNet.
    Deshpande BR; Rao SR; Jentes ES; Hills SL; Fischer M; Gershman MD; Brunette GW; Ryan ET; LaRocque RC; The Global TravEpiNet Consortium
    Am J Trop Med Hyg; 2014 Oct; 91(4):694-698. PubMed ID: 25070999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
    Liu W; Clemens JD; Kari K; Xu ZY
    Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies.
    Vodicka E; Zimmermann M; Lopez AL; Silva MW; Gorgolon L; Kohei T; Mooney J; Muhib F; Pecenka C; Marfin AA
    Vaccine; 2020 Mar; 38(13):2833-2840. PubMed ID: 32085954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.
    Erra EO; Kantele A
    Expert Rev Vaccines; 2015; 14(9):1167-79. PubMed ID: 26162529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese encephalitis vaccine in travelers.
    Jelinek T
    Expert Rev Vaccines; 2008 Jul; 7(5):689-93. PubMed ID: 18564023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response at 12-23 months following a single dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
    Krow-Lucal ER; Laven J; Perry L; Biggerstaff BJ; Johnson BW; Hollis E; Fischer M; Woolpert T; Hills SL
    Vaccine; 2020 Oct; 38(44):6899-6903. PubMed ID: 32907756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.